Home / Health / Diabetes Drug Launches in South Africa
Diabetes Drug Launches in South Africa
15 Jul
Summary
- Generic semaglutide injection approved for South African market.
- Once-weekly injectable treats type 2 diabetes alongside diet and exercise.
- Available soon in pre-filled pens in two dosage strengths.
Sun Pharmaceutical has secured regulatory approval from the South African Health Products Regulatory Authority for a generic version of semaglutide injection. This development positions South Africa as the second market, following India, to clear the diabetes drug.
The approved injectable is intended for adult use as an adjunct to diet and exercise for inadequately controlled type 2 diabetes mellitus. Patients can anticipate the launch of this once-weekly injectable in South Africa in the coming days.
It will be dispensed via a pre-filled, multi-dose pen, available in two distinct strengths: 2 mg/1.5 mL and 4 mg/3 mL. Sun Pharma highlighted its commitment to enhancing access to essential generic medicines and evidence-based treatments.
